Radioguided surgery with gallium 68 dotatate for patients with neuroendocrine tumors
JAMA Jan 22, 2019
El Lakis M, et al. - In this prospective cohort study, researchers evaluated the intraoperative techniques and thresholds that define positive lesions that warrant resection during Gallium 68 (68Ga)-dotatate radioguided surgery (RGS). Between October 23, 2013, and February 14, 2018, 44 patients with neuroendocrine tumors (NETs) who had 68Ga-dotatate RGS were included. Findings revealed that the lesions containing NETs had a higher tumor to background ratio (TBR) than those that did not contain NETs. The data presented in this work showed a TBR of 2.5 or more is a very sensitive threshold to indicate a lesion that is consistent with a NET on histological findings and therefore warrants surgical resection. Findings suggested that the omentum should be used as the background count activity for 68Ga-dotatate RGS for abdominal NETs patients.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries